Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 10
Submit an article Journal homepage
324
Views
23
CrossRef citations to date
0
Altmetric
Review

Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command

Mark S. Freedmana University of Ottawa, Ottawa, ON, CanadaCorrespondence[email protected]
,
Bruce Cohenb Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
,
Suhayl Dhib-Jalbutc Robert Wood Johnson Medical School, New Brunswick, NJ, USA
,
Douglas Jefferyd Wake Forest University School of Medicine, Winston-Salem, NC, USA
,
Anthony T. Redere University of Chicago, Chicago, IL, USA
,
Magnhild Sandberg-Wollheimf University Hospital, Lund, Sweden
&
Bianca Weinstock-Guttmang Jacobs Neurological Institute, Buffalo, NY, USA
 show all
Pages 2459-2470 | Accepted 02 Jul 2009, Published online: 13 Aug 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Andrea Berardi, Mohd Kashif Siddiqui, Catrin Treharne, Gerard Harty & Schiffon L. Wong. (2019) Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing–remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches. Current Medical Research and Opinion 35:8, pages 1371-1378.
Read now
Dirk Deleu, Boulenouar Mesraoua, Hisham El Khider, Beatriz Canibano, Gayane Melikyan, Hassan Al Hail, Noha Mhjob, Anjushri Bhagat, Faiza Ibrahim & Yolande Hanssens. (2017) Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar. Current Medical Research and Opinion 33:3, pages 439-458.
Read now
Stanley Cohan. (2016) Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis. Biologics: Targets and Therapy 10, pages 119-138.
Read now
B. Yamout, R. Alroughani, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, M. Sahraian, S. Khoury, Z. Alkawi, S. Koussa, M. Zakaria, J. Al Khaburi, T. Alsaadi & S. Bohlega. (2015) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Current Medical Research and Opinion 31:7, pages 1349-1361.
Read now
B. Yamout, R. Alroughani, M. Al-Jumah, S. Khoury, N. Abouzeid, M. Dahdaleh, I. Alsharoqi, J. Inshasi, S. Hashem, M. Zakaria, K. ElKallab, T. Alsaadi, T. Tawfeek & S. Bohlega. (2013) Consensus guidelines for the diagnosis and treatment of multiple sclerosis. Current Medical Research and Opinion 29:6, pages 611-621.
Read now
David W Brandes. (2010) The role of glatiramer acetate in the early treatment of multiple sclerosis. Neuropsychiatric Disease and Treatment 6, pages 329-336.
Read now

Articles from other publishers (17)

B. Yamout, M. Sahraian, S. Bohlega, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, S. Khoury, M Alkhawajah, S. Koussa, J. Al Khaburi, A. Almahdawi, T. Alsaadi, E. Slassi, S Daodi, M. Zakaria & R. Alroughani. (2020) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. Multiple Sclerosis and Related Disorders 37, pages 101459.
Crossref
Gabriel Pardo & David E. Jones. (2017) The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. Journal of Neurology 264:12, pages 2351-2374.
Crossref
O. V. Bykova, I. A. Nankina, I. M. Drozdova, O. V. Kvasova, T. T. Batysheva & A. N. Boiko. (2017) Multiple Sclerosis Disease-Modifying Drugs in Children and Adolescents. Neuroscience and Behavioral Physiology 47:5, pages 544-552.
Crossref
Raed Alroughani, Samar Farouk Ahmed, Raed Behbehani & Jasem Al-Hashel. (2017) The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study. Pediatric Neurology 70, pages 56-60.
Crossref
R. Alroughani, A. Ashkanani, J. Al-Hashel, R. Khan, A. Thussu, K.J. Alexander, P. Vembu, K. Sharfuddin, S. Lamdhade, J.K. John, S. Alkhashan, M. Abualmelh & S. Al-Shammri. (2016) Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait. Clinical Neurology and Neurosurgery 143, pages 51-64.
Crossref
O. V. Bykova, I. A. Nankina, I. M. Drozdova, O. V. Kvasova, T. T. Batysheva & A. N. Boiko. (2016) Disease-modifying drugs in pediatric patients with multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:2. Vyp. 2, pages 44.
Crossref
Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, Triantafyllos Doskas, Damianos Petrou, Nikolaos Makris, Nikolaos Vlaikidis, Thomas Thomaidis, Athanasios Kyritsis, Nikolaos Fakas, Xoulietta Treska, Clementine Karageorgiou, Stefania Sotirli, Christos Giannoulis, Dimitra Papadimitriou, Ioannis Mylonas, Evaggelos Kouremenos, Georgios Vlachos, Dimitrios Georgiopoulos, Despoina Mademtzoglou, Michalis Vikelis & Elias Zintzaras. (2014) Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA). PLoS ONE 9:11, pages e113933.
Crossref
M. S. Freedman. (2013) Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon‐ β therapy . European Journal of Neurology 21:3, pages 377.
Crossref
Maria Pia Sormani & Nicola De Stefano. (2013) Defining and scoring response to IFN-β in multiple sclerosis. Nature Reviews Neurology 9:9, pages 504-512.
Crossref
Bruce A. CohenBen W. ThrowerCarolyn A. BerryStephanie A. StowellWilliam A. MenciaRachel B. Karcher. (2013) Enhancing the quality of care for patients with multiple sclerosis through performance improvement CME. Neurology Clinical Practice 3:3, pages 240-248.
Crossref
Tanuja Chitnis. (2012) Disease-Modifying Therapy of Pediatric Multiple Sclerosis. Neurotherapeutics 10:1, pages 89-96.
Crossref
Amy Perrin Ross, June Halper & Colleen J. Harris. (2012) Assessing Relapses and Response to Relapse Treatment in Patients with Multiple Sclerosis. International Journal of MS Care 14:3, pages 148-159.
Crossref
T Chitnis, S Tenembaum, B Banwell, L Krupp, D Pohl, K Rostasy, E A Yeh, O Bykova, E Wassmer, M Tardieu, A Kornberg & A Ghezzi. (2011) Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis. Multiple Sclerosis Journal 18:1, pages 116-127.
Crossref
. (2011) Current World Literature. Current Opinion in Neurology 24:3, pages 300-307.
Crossref
Jordi Río, Manuel Comabella & Xavier Montalban. (2011) Multiple sclerosis: current treatment algorithms. Current Opinion in Neurology 24:3, pages 230-237.
Crossref
Brian C HealyBonnie I Glanz, James Stankiewicz, Guy Buckle, Howard Weiner & Tanuja Chitnis. (2010) A method for evaluating treatment switching criteria in multiple sclerosis. Multiple Sclerosis Journal 16:12, pages 1483-1489.
Crossref
J.J. Graber, C.A. McGraw, D. Kimbrough & S. Dhib-Jalbut. (2010) Overlapping and distinct mechanisms of action of multiple sclerosis therapies. Clinical Neurology and Neurosurgery 112:7, pages 583-591.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.